Using human cells, researchers developed a 3D experimental model that mimics the development of human bone marrow tissue that can be used to study chemotherapy toxicity.

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes ...

For women, there’s an added layer of complication: We are not the focus of the longevity lifehack movement, led by men like ...

Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...

In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and ...

Some promising studies on reverse aging suggest we could turn back the clock. Here's what experts want you to know about ...

An innovative new treatment is set to benefit hundreds of people in England with aggressive blood cancer after it was given ...

A new treatment, lisocabtagene maraleucel, has been approved for NHS use, benefiting hundreds of blood cancer patients in England.

Hundreds of people with aggressive blood cancer will be offered a groundbreaking one-off personalised therapy that ...

An ‘all clear’ at the end of treatment doesn’t necessarily mean the end of cancer. But new UK research aims to eliminate the ...

Avelumab plus axitinib was effective and safe in real-world advanced kidney cancer, with outcomes matching clinical trials, according to AVION study findings.